Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 21, 2023
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
Jacob Johnson Reiterated (CDXS) at Buy and Held Target at $6 on, Jul 21st, 2023
Jacob Johnson of Stephens & Co., Reiterated "Codexis, Inc." (CDXS) at Buy and Held Target at $6 on, Jul 21st, 2023.
Jacob has made no other calls on CDXS in the last 4 months.
There are 3 other peers that have a rating on CDXS. Out of the 3 peers that are also analyzing CDXS, 1 agrees with Jacob's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Swayampakula Ramakanth of "HC Wainwright & Co." Downgraded from Strong Buy to Hold on, Tuesday, May 9th, 2023
These are the ratings of the 2 analyists that currently disagree with Jacob
- Robert Wasserman of "Benchmark" Maintained at Strong Buy with Decreased Target to $9 on, Tuesday, May 9th, 2023
- Kashy Harrison of "Piper Sandler" Maintained at Buy with Decreased Target to $14 on, Monday, April 17th, 2023
